Forgot your password?

Forgot your username?

Aptiv Solutions Executive Discusses the State of Mobile Health Technology Regulatory

Posted on 23 Jun 2013
OneMedRadio spoke with Cynthia Nolte, Director, Medical Device Regulatory Services for Aptiv Solutions, about the state of mobile health/health information technology regulatory, clinical trial design for mobile health technology, and what we can expect from future guidelines. The con

Functional Neuromodulation CEO: Deep Brain Stimulation a Treatment for Alzheimer’s Disease

Posted on 18 Jun 2013
Charlottesville, VA-based Functional Neuromodulation is conducting an advanced trial of the application of Deep Brain Stimulation (DBS) therapy as a supplement for current Alzheimer’s Disease treatments. OneMedRadio’s Matt Margolis spoke with Dan O’Connell, co-founder and CEO of Funct

Can Avastin’s Shortcomings Open the Door for Del Mar Pharmaceuticals?

Posted on 14 Jun 2013
The effectiveness of Genentech and Roche's (RHHBY.OB) glioblastoma multiforme (GBM) treatment, Avastin, has recently been challenged raising concerns from physicians and patients alike that a huge void in patient care can develop if the FDA decides to revoke Avastin's approval for tre

Editor’s Note: June 6, 2013

Posted on 06 Jun 2013
Less than one month away from OneMedForumNY 2013, June 26-27 in New York City. We are excited to announce our preliminary presenting company schedule. You can view this list here. Our Sentinel this week features the second installment of our series on bioinformatics. Bioinformatics ha

Bioinformatics Part II: Application, Manipulation, and Uses

Posted on 06 Jun 2013
Or, How I Learned to Stop Worrying and Love Computational Biology.

Okairos: Okay After All

Posted on 05 Jun 2013
On May 29th, 2013, GlaxoSmithKline (GSK) announced the acquisition of Okairos in an all-cash deal worth $325 million US. The Okairos acquisition helps complement the pharma giant's existing vaccine technology and expertise and will enable GSK to continue its work developing the next g

NanoViricides: Big Things In a Small Package

Posted on 04 Jun 2013
During an interview with OneMedPlace, President and Chairman of NanoViricides (NNVC) Anil Diwan summed up the influenza treatment market in just a few words: It is like trying to hit a moving target.

Cyto Wave Technologies CEO: First Device to Detect Circulating Tumor Cells In Vivo

Posted on 03 Jun 2013
Cyto Wave Technologies' iV3 device can detect circulating tumor cells in real time via laser technology and potentially destroy cells. OneMedRadio spoke with Cyto Wave Technologies President and CEO George Yu about the favorable on-ramp to commercialization, clearing regulatory and re

RELEASE: Mercator MedSystems Raises Additional $6.5 Million

Posted on 03 Jun 2013
Mercator MedSystems, Inc., a privately-held medical technology company reinventing the treatment of disease deep inside the body, today announced the closing of a $6.5 million Series B financing. The funding will be used to initiate sales of its Cricket™ and Bullfrog® Micro-Infusion d